Medicines for Malaria Venture

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) ‹ The template below (Promotional) is being considered for merging. See templates for discussion to help reach a consensus. › This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (May 2018) (Learn how and when to remove this message) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Medicines for Malaria Venture" – news · newspapers · books · scholar · JSTOR (September 2012) (Learn how and when to remove this message) (Learn how and when to remove this message)

Medicines for Malaria Venture (MMV) is a not-for-profit public-private partnership that was established as a foundation in Switzerland in 1999. Its main mission is to reduce malaria in disease-endemic countries by developing and facilitating the delivery of antimalarial drugs.